keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...
Published 5 years ago • 138 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
8:25
pembrolizumab comparable to chemotherapy for patients with advanced gastric or gastroesophageal ...
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
1:36
keynote-062 highlights role of pembrolizumab in gastric/gej cancer subtypes
-
1:47
quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal juncti...
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
0:54
perioperative pembrolizumab for stomach cancer treatment
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
8:45
keynote-590: pembrolizumab plus chemotherapy for advanced oesophageal cancer
-
1:56
josep tabernero, md, phd, offers perspective on keynote-062 in advanced gastroesophageal
-
6:03
fight updates: bemarituzumab with folfox6 in fgfr2b advanced gastric/gastroesophageal junction ...
-
4:50
comment: reasonable to conclude that pembrolizumab is non-inferior to chemotherapy
-
1:54
pembrolizumab in advanced gastric cancer treatment
-
4:24
mike gibson, asco 2019 - keynote-062 and keynote-48 trial data
-
6:32
latest results from keynote-181: pembrolizumab versus chemotherapy as a second-line therapy for ...
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
56:48
immunotherapy for gastroesophageal cancer